Over the five years to 2017, demand for women's health hospitals has grown, as rising disposable income and a falling unemployment rate, coupled with the Patient Protection and Affordable Care Act (PPACA), have increased insurance coverage in the United States. These same factors have contributed to growth in the US birth rate as well as the total annual number of doctor's visits. Federal and state mandates to test and vaccinate young women against the human papillomavirus (HPV) have further supported this growth. Over the five years to 2022, the outlook for the industry is positive, barring any drastic government regulation changes. Along with the steadily recovering economy and continually rising US birth rate, expanded insurance coverage under the PPACA will continue to drive industry revenue growth. With demand rising, the number of industry employees is also set to rise, and the resulting increase in wages will likely continue to constrain profit growth over the next five years.
This industry includes specialty hospitals that primarily provide diagnostic and medical treatment to inpatients with health issues specific to female anatomy. Women’s health issues often relate to structures such as female genitalia and breasts or to conditions caused by hormones specific to females. Women’s health hospitals treat a specific type of disease or medical condition (except psychiatric conditions or substance abuse), maintain inpatient beds and provide food services.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.